Education＆ScienceResearch fund opportunities
2022-2024 Cell and Molecular Biology Assembly “Developing a novel synthetic lethal treatment with targeting long non-coding RNA (lncRNA) for KRAS-mutated lung cancer”
Team members:
Principal Investigator:
Dr Mitsuo Sato, Assembly Deputy Head (Japan)
Co-Investigators:
Dr Ichidai Tanaka (Japan)
Dr Kazuhide Sato (Japan)
Project term:
1 April 2022 – 31 March 2024
Research Achievements will be presented at APSR 2024 Hong Kong Congress.